![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Hematologic Analysis of Paritaprevir(ABT-450)/r/Ombitasvir
and Dasabuvir + RBV in TURQUOISE-I
|
|
|
Reported by Jules Levin
CROI 2015
Feb 23-26, Seattle, WA
Mark Sulkowski1, David Wyles2, Jihad Slim3, Peter J Ruane4, Barbara McGovern5, Roger Trinh5, Joseph J Eron6
1Johns Hopkins University, Balti more, Maryland, United States; 2University of California San Diego, La Jolla, California, United States; 3St. Michael's Medical Center, Seton Hall University, Newark, New Jersey, United States; 4Ruane Medical and Liver Health Insti tute, Los Angeles, California, United States; 5AbbVie Inc., North Chicago, Illinois, United States; 6University of North Carolina, Chapel Hill, North Carolina, United States
![CROI1.gif](../images/032515/032515-1/CROI1.gif)
![CROI2.gif](../images/032515/032515-1/CROI2.gif)
![CROI3.gif](../images/032515/032515-1/CROI3.gif)
![CROI4.gif](../images/032515/032515-1/CROI4.gif)
![CROI5.gif](../images/032515/032515-1/CROI5.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|